Jiangsu Hengrui Medicine Co., Ltd.

This early-stage study tests a new drug called HRS-7172 in 120 adults with advanced solid tumors that have RAS mutations or amplifications. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. Researchers will also watch for signs …

This early-stage trial is testing a new radioactive drug called HRS-6768 in people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find a safe and effective dose while checking how the drug moves through the body and delivers radi…